We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Asthma in the Elderly: The Role of Exhaled Nitric Oxide Measurements

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00939354
First Posted: July 15, 2009
Last Update Posted: October 29, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Michele Columbo, M.D., Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
July 14, 2009
July 15, 2009
October 29, 2015
July 2009
February 2011   (Final data collection date for primary outcome measure)
Exhaled Nitric Oxide (FENO) levels and their changes with time [ Time Frame: One year ]
Not Provided
Complete list of historical versions of study NCT00939354 on ClinicalTrials.gov Archive Site
Correlations of FENO with subjects' demographics, comorbidities, treatment, symptoms, or spiromentric values [ Time Frame: One year ]
Not Provided
Not Provided
Not Provided
 
Asthma in the Elderly: The Role of Exhaled Nitric Oxide Measurements
Asthma in the Elderly: The Role of Exhaled Nitric Oxide Measurements
This study will investigate the importance of exhaled nitric oxide measurements in subjects with asthma age 65 and older. This group of patients has been ignored in most previous asthma studies.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Subjects with asthma over the age of 65 who are currently followed in our practice
Asthma
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
30
February 2011
February 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Subjects with asthma over the age of 65 followed in our practice, non-smokers and able to give informed consent to participate in the study

Exclusion Criteria:

  • Smokers, subjects of diminished mental capacity
Sexes Eligible for Study: All
65 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
United States
 
NCT00939354
F/N-R09-2839B
No
Not Provided
Not Provided
Michele Columbo, M.D., Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
Not Provided
Principal Investigator: Albert S Rohr, M.D. Rohr and Columbo Associates
Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
October 2015